Skip to main content
Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · IEX Real-Time Price · USD
4.120
-0.010 (-0.24%)
At close: Apr 25, 2024, 4:00 PM
3.920
-0.200 (-4.85%)
After-hours: Apr 25, 2024, 4:36 PM EDT

Evaxion Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
0.0700000
Gross Profit
0.0700000
Selling, General & Admin
10.358.216.255.672.651.9
Research & Development
11.9217.0619.5810.98.223.73
Operating Expenses
22.2725.2625.8316.5710.865.63
Operating Income
-22.2-25.26-25.83-16.57-10.86-5.63
Interest Expense / Income
1.681.510.920.221.220.72
Other Expense / Income
-0.96-2.83-2.04-0.22-0.07-0.08
Pretax Income
-22.92-23.94-24.71-16.58-12.02-6.27
Income Tax
-0.79-0.77-0.18-1.56-0.83-0.74
Net Income
-22.13-23.17-24.53-15.02-11.2-5.54
Shares Outstanding (Basic)
2823191919-
Shares Change
19.12%20.86%1.32%---
EPS (Basic)
-8.10-9.80-12.60-9.70-8.10-4.30
EPS (Diluted)
-8.10-9.80-12.60-9.70-8.10-4.30
Free Cash Flow
-17.78-26.07-23.29-12.62-7.08-2
Free Cash Flow Per Share
-6.43-11.23-12.13-6.66-3.74-
Gross Margin
100.00%-----
Operating Margin
-30406.85%-----
Profit Margin
-30308.22%-----
Free Cash Flow Margin
-24353.42%-----
EBITDA
-21.23-22.43-23.8-16.35-10.8-5.55
EBITDA Margin
-29087.67%-----
EBIT
-21.23-22.43-23.8-16.35-10.8-5.55
EBIT Margin
-29087.67%-----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).